CVS Caremark faces class-action lawsuit for sending political texts in Louisiana
A legal action has been launched by a Louisiana law firm against CVS Caremark for allegedly using patient data to distribute political text messages, prompting outrage from the recipients. The messages urged individuals to oppose legislation designed to regulate pharmacy benefit managers (PBMs) during the regular legislative session in 2025.
Following the passage of HB 358 by both the House and Senate, CVS customers in Louisiana woke up to a message stating that the company would be forced to close its establishments in the state. CVS Caremark, a subsidiary of CVS Health Corporation, stands as one of the largest PBMs in the country, responsible for managing prescription benefits for a vast number of Americans.
Two bills were the focal point of the political texts. The first one, House Bill 264, successfully made its way through the legislative process, requiring PBMs to disclose more rebates and discounts to patients and employer plans. Additionally, it prohibited PBMs from directing patients to specific pharmacies, a practice criticized for benefiting companies like CVS that have a dual role in managing benefits and operating retail pharmacies.
Conversely, the second bill, HB 358, failed to garner the support needed to pass in the legislature. This bill aimed to prohibit PBMs from owning pharmacies altogether. Speculations are rife that a special session could be convened to address this issue, similar to the situation in Arkansas where CVS and other PBMs have taken legal action against the state’s new law. This legal fracas has prompted concerns that if Louisiana proceeds with further actions against PBMs, a wave of lawsuits similar to the one in Arkansas may ensue.
The class-action lawsuit against CVS alleges that the company used confidential patient information to advocate against the bills, a move deemed as a breach of patient privacy and state laws. This move has sparked a response from Gov. Jeff Landry, who has directed the Attorney General’s Office to look into the matter.
Given the gravity of the situation, it is imperative to ensure that patient confidentiality and privacy are upheld, steering clear from any misuse of confidential data for political purposes. The legal battle between CVS Caremark and the state of Louisiana signifies a monumental clash between corporate interests and the protection of patient rights and privacy in the realm of healthcare legislation.